To access this element change to forms mode OFF
Grant Award View - GA214905
Preventing reperfusion injury in stroke with an acutely dosed NK1R...
GA ID:
GA214905
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
21-Nov-2021
Publish Date:
24-Jan-2022
Category:
Health and Medical Research
Grant Term:
1-Jan-2022 to 31-Jan-2024
Value (AUD):
$660,715.92
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Development Grants
Grant Activity:
Preventing reperfusion injury in stroke with an acutely dosed NK1R antagonist prodrug
Purpose:
Stroke represents a major clinical and societal burden (on individuals and society) and is the primary cause of adult disability, second-most common cause of dementia, and third-leading cause of death. We will develop a novel and effective intravenous form of a compound known to act beneficially in these clinical settings. This form of administration will act quickly and more effectively with beneficial stroke victim outcomes.
GO ID:
GO Title:
NHMRC Development Grants 2021 for funding in 2022
Internal Reference ID:
2021/GNT2013973
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA